The Valley Desk

NCT06721689 · Interventional trial

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

Overall registry status Recruiting

Phase 1 · Phase 2

Conditions Refractory Neuroblastoma, Refractory Rhabdomyosarcoma, Refractory Solid Tumors, Relapsed Neuroblastoma, Relapsed Rhabdomyosarcoma, Relapsed Solid Tumors

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov